This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: University Court of the University of St. Andrews, University of Dundee. Active years: 2013-2015.
Company Filing History:
2 out of 163 
2 out of 108 
Years Active: 2013-2015
Title: Michael John Raymond Stark: Innovations in P53 Activating Compounds
Introduction
Michael John Raymond Stark, an innovative inventor based in Newport on Tay, GB, has made significant contributions in the field of biotechnology. His work focuses primarily on P53 activating compounds, which are crucial in the fight against hyperproliferative diseases like cancer.
Latest Patents
Stark holds two patents that showcase his groundbreaking research. His latest invention revolves around P53 activating compounds, which activate the p53 response, finding applications in cancer treatment and other diseases involving sirtuin function. This novel approach aims to enhance therapeutic strategies against various conditions where p53 responses are critical.
Career Highlights
Throughout his career, Stark has worked at esteemed institutions such as the University Court of the University of Dundee and the University Court of the University of St. Andrews. His tenure at these universities allowed him access to advanced research environments, facilitating the development of his innovative compounds.
Collaborations
Stark has collaborated with notable professionals in the field, including Sonia Lain and David Phillip Lane. These partnerships have enriched his research, enabling him to explore diverse aspects of P53 function and its therapeutic implications.
Conclusion
In summary, Michael John Raymond Stark is an accomplished inventor whose work on P53 activating compounds represents a significant advancement in medical research. His dedication to combating hyperproliferative diseases continues to impact the scientific community and offers hope for improved treatment options in the future.